Stelios Papadopoulos - 26 Feb 2026 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Reporting relationship: Director
Issuer ticker: OVID
Reported as of: 26 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Mar 2026, 16:30:20 UTC
Prior SEC filing: 13 Nov 2025
Next SEC filing: 09 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Rona, Attorney-in-Fact

Key filing fact

Stelios Papadopoulos filed Form 4 for Ovid Therapeutics Inc. (OVID) on 02 Mar 2026.

Key facts

This page summarizes Stelios Papadopoulos's Form 4 filing for Ovid Therapeutics Inc. (OVID).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Mar 2026, 16:30.

Change

Previous filing in this sequence was filed on 13 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001202098 Primary reporting owner

PAPADOPOULOS STELIOS

Relationship: Director
Address: C/O OVID THERAPEUTICS INC., 441 NINTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Jeffrey Rona, Attorney-in-Fact
Signature date: 02 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OVID transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +65,000
Change %
Price: $0.000000
Shares after: 65,000
Date: 26 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 65,000
Exercise price: $1.65
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest in full on February 26, 2027, subject to the Reporting Person's continuous service through such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .